If the negotiated settlement includes a modestly delayed Amphastar launch....
IMHO, the fact of the PI shows that it is more likely than not that the '466 patent is strong enough to obviate the need for MNTA to concede such a settlement, and all we are seeing here is the respective CFOs of MNTA and Sandoz allocating hypothetical damages based on their read of the mostly likely actual future profits/royalties split based on the Sanofi AG.
Market Data 
Markets 
AI
